Int J Arrhythm.  2016 Mar;17(1):51-55. 10.18501/arrhythmia.2016.008.

Peri-procedural Management of Anticoagulation Therapy (cataract eye surgery, dental procedure and gastrointestinal endoscopy)

• Chung JW

• KMID: 2308909
• DOI: http://doi.org/10.18501/arrhythmia.2016.008

Abstract

Anticoagulation therapy is widely used to prevent thromboembolism in patients with atrial fibrillation, venous thromboembolism, and mechanical heart valves. The temporary interruption of anticoagulants is common to reduce the bleeding risk during peri-procedures. Traditionally, warfarin was held for several days before procedures with heparin bridging therapy. However, recent data showed that stopping warfarin was not necessary before procedures with a low bleeding risk, such as a gastrointestinal endoscopy, cataract eye surgery, and dental procedures when the thromboembolic risk of the patient is moderate-to-high. This review article outlines the estimation of the thromboembolic and bleeding risk before procedures, and determines the timing of anticoagulant interruption.

Keyword

Anticoagulants; Procedures; Cataract; Tooth Extraction; Endoscopy

MeSH Terms

Anticoagulants
Atrial Fibrillation
Cataract
Endoscopy
Endoscopy, Gastrointestinal
Heart Valves
Hemorrhage
Heparin
Humans
Thromboembolism
Tooth Extraction
Venous Thromboembolism
Warfarin
Anticoagulants
Heparin
Warfarin